IDEAYA Biosciences Q4 Results Misses Estimates
(RTTNews) - IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
Collaboration revenues for the quarter declined to $3.92 million from $4.02 million in the same quarter last year.
On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.47 per share on revenues of $8.84 million for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews
|
Pred 434 dňami
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.
RTTNews
|
Pred 700 dňami
Sensex, Nifty Snap Five-day Losing Streak
Indian shares rose notably on Monday as concerns over Middle East tensions eased and private sector lender ICICI Bank posted robust Q2 numbers.
RTTNews
|
Pred 5 h 9 min
Philips Cuts FY24 Sales View On Weak China Demand; Shares Hit
Shares of Philips N.V. were losing around 17 percent in the morning trading in Amsterdam as well as in pre-market activity on the NYSE, after the Dutch consumer electronics giant trimmed its comparable sales growth view for fiscal 2024 after reporting weak sales and orders and flat comparable sales in its third quarter. The sales mainly were hit by further deteriorated demand in China.
RTTNews
|
Pred 5 h 23 min
European Shares Gain Ahead Of Busy Week
European stocks were broadly higher on Monday ahead of a busy week for earnings and economic releases.
RTTNews
|
Pred 6 h 1 min
FTSE 100 Marginally Higher Ahead Of Budget
U.K. stocks were slightly higher on Monday ahead of Prime Minister Sir Keir Starmer's new government's first budget to be unveiled on Wednesday and the release of the widely watched monthly U.S. jobs report due on Friday.
RTTNews
|
Pred 6 h 16 min
CAC 40 Rallies After Israel's Calibrated Attack On Iran
French stocks rallied on Monday after Israel pounded Iran with a series of airstrikes early Saturday in retaliation for the barrage of ballistic missiles the Islamic Republic fired upon Israel on October 1.
RTTNews
|
Pred 6 h 29 min
DAX Rises As Middle East Tensions Ease
German stocks were modestly higher on Monday ahead of a busy week for earnings and economic data releases.
RTTNews
|
Pred 6 h 42 min
